BRIACELL THERAPEUTICS CORP. Adjustments For Decrease Increase In Trade Account Receivable
BRIACELL THERAPEUTICS CORP. (BCTX) reported Adjustments For Decrease Increase In Trade Account Receivable of -$1.96 thousand for the 9-month period ending 2022-04-30, per its 6-K filed 2022-06-13.
Discontinued › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable · last filed 2022-06-13
CAD
| Period end | Adjustments For Decrease Increase In Trade Account Receivable 0 month | Adjustments For Decrease Increase In Trade Account Receivable 12 month |
|---|---|---|
| 2020-07-31 | -24.20K CAD 40-F/A · filed 2021-11-16 | |
| 2019-08-01 | 15.52K CAD 40-F/A · filed 2021-11-16 |
USD
| Period end | Adjustments For Decrease Increase In Trade Account Receivable 0 month | Adjustments For Decrease Increase In Trade Account Receivable 3 month | Adjustments For Decrease Increase In Trade Account Receivable 6 month | Adjustments For Decrease Increase In Trade Account Receivable 9 month | Adjustments For Decrease Increase In Trade Account Receivable 12 month |
|---|---|---|---|---|---|
| 2022-04-30 | $12.63K derived: 6-K 9 month − 6-K 6 month · filed 2022-06-13 | -$1.96K 6-K · filed 2022-06-13 | |||
| 2022-01-31 | -$14.59K 6-K · filed 2022-03-15 | ||||
| 2021-07-31 | $3.23K derived: 40-F/A 12 month − 6-K 9 month · filed 2021-11-16 | -$7.75K derived: sum of 2 quarters · filed 2022-06-13 | $9.94K 40-F/A · filed 2021-11-16 | ||
| 2021-04-30 | -$10.97K derived: 6-K 9 month − 6-K 6 month · filed 2022-06-13 | $6.71K 6-K · filed 2022-06-13 | |||
| 2021-01-31 | $17.69K 6-K · filed 2022-03-15 | ||||
| 2020-07-31 | -$22.52K 40-F/A · filed 2021-11-16 | ||||
| 2019-08-01 | $12.63K 40-F/A · filed 2021-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |